Related Experiment Videos

[Effect of kanamycin on kidney function in children with suppurative, inflammatory diseases]

Antibiotiki
|August 1, 1976
PubMed

Insights

Kanamycin did not harm kidney function in children, even at higher doses. Combining kanamycin with pentoxyl improved kidney function and reduced protein and white blood cells in urine.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Pharmacology

Context:

  • Kanamycin is an antibiotic used to treat serious bacterial infections.
  • Nephrotoxicity is a known potential side effect of kanamycin therapy.
  • Pyrimidines, like pentoxyl, are being investigated for their potential to mitigate antibiotic side effects.

Purpose:

  • To evaluate the nephrotoxic effects of kanamycin in pediatric patients.
  • To assess the efficacy of pentoxyl in reducing kanamycin-induced kidney damage.
  • To determine safe and effective therapeutic doses of kanamycin in children.

Summary:

  • A study involving 240 children (2 months to 14 years) with osteomyelitis or staphylococcal lung infections investigated kanamycin's renal effects.
  • Kanamycin, administered at 15,000-25,000 Units/kg for 6-7 days, showed no nephrotoxic impact.
  • Concurrent administration with pentoxyl, a pyrimidine derivative, significantly enhanced kidney function, indicated by improved residual nitrogen levels and glomerular filtration, and reduced albuminuria and leucocyturia.

Impact:

  • The findings support the use of higher therapeutic doses of kanamycin (up to 25,000 Units/kg) in pediatric patients.
  • This research highlights the potential of pentoxyl to mitigate kanamycin's adverse renal effects.
  • Constant monitoring of kidney function is recommended when using these higher kanamycin dosages.

Related Concept Videos